BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21332734)

  • 21. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM; Davies BJ; Brennan PA
    Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates and the dental practitioner--a guide to management.
    Williamson R
    Ann R Australas Coll Dent Surg; 2010 Mar; 20():46-9. PubMed ID: 22046734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S; Farooki A
    Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates and bone...what have we learned?
    Guttenberg SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534
    [No Abstract]   [Full Text] [Related]  

  • 30. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
    Dickinson M; Prince HM; Kirsa S; Zannettino A; Gibbs SD; Mileshkin L; O'Grady J; Seymour JF; Szer J; Horvath N; Joshua DE
    Intern Med J; 2009 May; 39(5):304-16. PubMed ID: 19220531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate-related osteonecrosis of the jaw in cancer patients: Implications for nurses.
    Morris M; Cruickshank S
    Eur J Oncol Nurs; 2010 Jul; 14(3):205-10. PubMed ID: 20129822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ; Ramalingam L; Zacharin MR
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.
    Hoff AO; Toth B; Hu M; Hortobagyi GN; Gagel RF
    Ann N Y Acad Sci; 2011 Feb; 1218():47-54. PubMed ID: 20946574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate related osteonecrosis of the jaws.
    Shah SA; Aslam A; Mirza AI; Ali S
    J Ayub Med Coll Abbottabad; 2010; 22(3):214-7. PubMed ID: 22338459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S; Liardo C; Puzzo S
    Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of bisphosphonates on oral health: lessons from the past and opportunities for the future.
    Zavras AI
    Ann N Y Acad Sci; 2011 Feb; 1218():55-61. PubMed ID: 21291477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.